APPLICATION
ANDA202501
TYPE
ANDA
ORIGINAL APPROVAL
2012-07-26
LATEST ACTION
2013-01-17
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
CIDOFOVIRPrescription
CIDOFOVIR EQ 375MG BASE/5ML (EQ 75MG BASE/ML) · SOLUTION · INTRAVENOUS
Approval history
2013-01-17Labeling · Supplement 1 · standardAP
2012-07-26UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.